[1] Anand A C, Nandi B, Acharya S K, et al. Indian National Association for the study of the liver consensus statement on acute liver failure (part 1): epidemiology, pathogenesis, presentation and prognosis[J]. J Clin Exp Hepatol, 2020,10(4): 339-376. [2] 中华医学会感染疾病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南[J]. 临床肝胆病杂志,2019,35(1):38-44. [3] 邓存良,王波,李烨. 肝衰竭预后预测模型及预测因素[J]. 西部医学,2018,30(01):3-7. [4] Du W B, Pan X P, Li L J. Prognostic models for acute liver failure[J]. Hepatobiliary Pancreat Dis Int, 2010, 9(2): 122-128. [5] Chen W, You J, Chen J, et al. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. World J Gastroenterol, 2017,23(40): 7303-7309. [6] Ozcay F, Karadag Oncel E, Baris Z, et al. Etiologies, outcomes, and prognostic factors of pediatric acute liver failure: a single center's experience in Turkey[J].Turk J Gastroenterol, 2016,27(5): 450-457. [7] 李会,王永刚,苏海滨. 血乳酸水平在评估肝衰竭患者预后中的应用[J]. 临床肝胆病杂志,2020,36(11): 2609-2612. [8] 涂颖,李雪,陈美娟,等. 血小板计数及相关评分模型对HBV相关慢加急性肝衰竭预后的预测价值[J]. 临床肝胆病杂志,2023,39(6):1308-1312. [9] 李艳艳,欧阳兵,徐龙. 血清前白蛋白、INR及MELD评分与肝衰竭患者预后的关系[J]. 江西医药,2019, 54(03):228-230. [10] 杨洋,李秀惠. HBV相关慢加急(亚急)性肝衰竭患者血清AFP、CA199临床意义的研究[J]. 医学信息, 2019, 32(09):61-64. |